GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » Days Sales Outstanding

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Days Sales Outstanding : 54.75 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Days Sales Outstanding?

Laboratorios Farmaceuticos Rovi's average Accounts Receivable for the three months ended in Dec. 2023 was €140.8 Mil. Laboratorios Farmaceuticos Rovi's Revenue for the three months ended in Dec. 2023 was €234.6 Mil. Hence, Laboratorios Farmaceuticos Rovi's Days Sales Outstanding for the three months ended in Dec. 2023 was 54.75.

The historical rank and industry rank for Laboratorios Farmaceuticos Rovi's Days Sales Outstanding or its related term are showing as below:

XMAD:ROVI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 63.74   Med: 69.89   Max: 91.69
Current: 70.12

During the past 13 years, Laboratorios Farmaceuticos Rovi's highest Days Sales Outstanding was 91.69. The lowest was 63.74. And the median was 69.89.

XMAD:ROVI's Days Sales Outstanding is ranked better than
52.3% of 893 companies
in the Biotechnology industry
Industry Median: 73.34 vs XMAD:ROVI: 70.12

Laboratorios Farmaceuticos Rovi's Days Sales Outstanding declined from Dec. 2022 (62.20) to Dec. 2023 (54.75).


Laboratorios Farmaceuticos Rovi Days Sales Outstanding Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi Days Sales Outstanding Chart

Laboratorios Farmaceuticos Rovi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.83 68.64 63.74 73.69 71.13

Laboratorios Farmaceuticos Rovi Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.03 73.01 56.42 54.75 86.51

Competitive Comparison of Laboratorios Farmaceuticos Rovi's Days Sales Outstanding

For the Biotechnology subindustry, Laboratorios Farmaceuticos Rovi's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorios Farmaceuticos Rovi's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Days Sales Outstanding falls into.



Laboratorios Farmaceuticos Rovi Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Laboratorios Farmaceuticos Rovi's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (180.011 + 143.314) / 2 ) / 829.509*365
=161.6625 / 829.509*365
=71.13

Laboratorios Farmaceuticos Rovi's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (138.267 + 143.314) / 2 ) / 234.636*365 / 4
=140.7905 / 234.636*365 / 4
=54.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorios Farmaceuticos Rovi  (XMAD:ROVI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Laboratorios Farmaceuticos Rovi Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Traded in Other Exchanges
Address
Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.